Alyeska Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-330,752
Closed -$31.5M 673
2025
Q3
$31.5M Sell
330,752
-286,748
-46% -$26.4M 0.1% 236
2025
Q2
$53.8M Sell
617,500
-2,256,123
-79% -$191M 0.19% 148
2025
Q1
$258M Buy
2,873,623
+1,442,768
+101% +$129M 1.03% 10
2024
Q4
$114M Buy
+1,430,855
New +$124M 0.43% 56
2023
Q1
Sell
-744,442
Closed -$57.9M 511
2022
Q4
$57.9M Buy
+744,442
New +$60.3M 0.6% 49
2022
Q2
Sell
-277,350
Closed -$30.8M 627
2022
Q1
$30.8M Sell
277,350
-189,650
-41% -$20M 0.34% 103
2021
Q4
$48.3M Buy
+467,000
New +$54.1M 0.56% 56
2020
Q2
Sell
-512,331
Closed -$46.2M 545
2020
Q1
$46.2M Buy
+512,331
New +$54.5M 0.92% 30
2019
Q2
Sell
-225,000
Closed -$20.5M 493
2019
Q1
$20.5M Buy
+225,000
New +$20.1M 0.27% 119
2017
Q3
Sell
-482,264
Closed -$42.8M 505
2017
Q2
$42.8M Buy
+482,264
New +$40.7M 0.36% 101
2016
Q2
Sell
-737,754
Closed -$55.3M 470
2016
Q1
$55.3M Buy
737,754
+685,499
+1,312% +$51.6M 0.51% 62
2015
Q4
$4.02M Buy
+52,255
New +$3.93M 0.04% 270
2015
Q2
Sell
-664,601
Closed -$51.8M 540
2015
Q1
$51.8M Buy
+664,601
New +$50.4M 0.72% 16
2014
Q3
Sell
-169,800
Closed -$10.8M 425
2014
Q2
$10.8M Buy
+169,800
New +$10.3M 0.24% 150
2014
Q1
Sell
-305,000
Closed -$17.5M 364
2013
Q4
$17.5M Buy
305,000
+25,000
+9% +$1.42M 0.69% 36
2013
Q3
$14.9M Buy
280,000
+60,000
+27% +$3.23M 0.61% 52
2013
Q2
$11.3M Buy
+220,000
New +$10.9M 0.56% 54

Other funds holding MDT

Alyeska Investment Group's MDT Position: Q4 2025 in Review

Alyeska Investment Group sold out of Medtronic (MDT) in Q4 2025, closing a stake of 330,752 shares — an estimated $31.5M sold.

Alyeska Investment Group first reported a position in MDT in Q2 2013 and held it in 17 quarters. The position peaked at $258M in Q1 2025. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Alyeska Investment Group reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 330,752 Medtronic shares in Q4 2025, an estimated $31.5M.
  • Alyeska Investment Group first reported a position in Medtronic in Q2 2013 and held it in 17 quarters.
  • Alyeska Investment Group's Medtronic position peaked at $258M in Q1 2025.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.